News for Healthier Living

Yale Study Sheds Light on Cellular Resistance to Osimertinib in Adenocarcinoma

Some lung cancers manage to overcome a targeted drug therapy despite it showing initial success. Yale researchers have now discovered a molecular-level resistance mechanism that begins to take hold as early as six to eight weeks after the cancer drug is introduced. They reported their findings Oct. 23 in Nature Structural and Molecular Biology.

November 18, 2025


November 18 2025

November 17 2025

November 16 2025

November 15 2025

November 14 2025

November 13 2025

November 12 2025

November 11 2025

November 10 2025

November 9 2025

November 8 2025

November 7 2025

November 6 2025

November 5 2025